Cited by

• A Review of Human Herpesvirus 8, the Kaposi's Sarcoma-Associated Herpesvirus, in the Pediatric Population.

  Dow DE, Cunningham CK, Buchanan AM. Dow DE, et al. J Pediatric Infect Dis Soc. 2014 Mar;3(1):66-76. doi: 10.1093/jpids/pit051. Epub 2013 Sep 4. J Pediatric Infect Dis Soc. 2014. PMID: 24567845 Free PMC article. Review.
• Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study.

  Polizzotto MN, Uldrick TS, Wyvill KM, Aleman K, Peer CJ, Bevans M, Sereti I, Maldarelli F, Whitby D, Marshall V, Goncalves PH, Khetani V, Figg WD, Steinberg SM, Zeldis JB, Yarchoan R. Polizzotto MN, et al. J Clin Oncol. 2016 Dec;34(34):4125-4131. doi: 10.1200/JCO.2016.69.3812. Epub 2016 Oct 31. J Clin Oncol. 2016. PMID: 27863194 Free PMC article. Clinical Trial.
• Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.

  Casper C, Krantz EM, Corey L, Kuntz SR, Wang J, Selke S, Hamilton S, Huang ML, Wald A. Casper C, et al. J Infect Dis. 2008 Jul 1;198(1):23-30. doi: 10.1086/588820. J Infect Dis. 2008. PMID: 18491970 Free PMC article. Clinical Trial.
• A Prospective Study Assessing Tumour Response, Survival, and Palliative Care Outcomes in Patients with HIV-Related Kaposi's Sarcoma at Queen Elizabeth Central Hospital, Blantyre, Malawi.

  Francis H, Bates MJ, Kalilani L. Francis H, et al. AIDS Res Treat. 2012;2012:312564. doi: 10.1155/2012/312564. Epub 2012 Mar 11. AIDS Res Treat. 2012. PMID: 22496970 Free PMC article.
• Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.

  Uldrick TS, Wyvill KM, Kumar P, O'Mahony D, Bernstein W, Aleman K, Polizzotto MN, Steinberg SM, Pittaluga S, Marshall V, Whitby D, Little RF, Yarchoan R. Uldrick TS, et al. J Clin Oncol. 2012 May 1;30(13):1476-83. doi: 10.1200/JCO.2011.39.6853. Epub 2012 Mar 19. J Clin Oncol. 2012. PMID: 22430271 Free PMC article. Clinical Trial.